NCT01689194

Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer

A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 53 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial is Phase II trial for evaluating efficacy of induction chemotherapy using Genexol-PM + cisplatin for locally advanced head and neck cancer. The investigators try to evaluate response rate of Genexol-PM + cisplatin chemotherapy, and safety profile.

Conditions

• Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

Type	Name	Description
DRUG	genexolPM + cisplatin

Timeline

• Start date: 2013-02-01
• Primary completion: 2016-04-01
• Completion: 2017-08-31
• First posted: 2012-09-21
• Last updated: 2020-12-08

Locations

2 sites across 1 country: South Korea